Status:

COMPLETED

Eye-ECG Approach to Emergencies : Diagnostic Performance of the HINTS Test

Lead Sponsor:

Fondation Hôpital Saint-Joseph

Conditions:

Acute Vestibular Syndrome

Emergencies

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Vertigo integrated with acute vestibular syndrome (AVS) is a frequent reason for emergency visits. The French and international literature estimates between 2 to 4% of vertigo prevalence among reasons...

Detailed Description

The HINTS test (Head Impulse, Nystagmus, Test of Skew) is a clinical test composed of 3 oculomotor examinations: the search for high frequency vestibulo-ocular reflex during a passive impulse of the h...

Eligibility Criteria

Inclusion

  • French-speaking patient.
  • Affiliated with social security or, failing that, with another health insurance system.
  • Patient capable of giving free, informed and express consent
  • Patient with an isolated AVS defined by a progression of more than one hour and less than one month and at least one of the following criteria:
  • Vertigo (illusion of the subject moving in relation to surrounding objects or objects) surrounding with respect to the subject, a sensation of rotation, movement of the body in the plane vertical, unstable, described as a pitch or "rotating head"), sometimes associated with vegetative signs (nausea, vomiting, pallor, sweating, slowing of frequency cardiac),
  • A nystagmus (spontaneous or positional),
  • Ataxia characterized by gait disorders with imbalance type (which can dominate the symptomatology) with sways, a brittle gait or simple instability.
  • A patient may be included several times during the study period provided that they are acute episodes separate.

Exclusion

  • Patient with focal neurological signs concomitantly appearing with AVS: disorder of the language or writing, speech impairment, dysarthria, movement performance disorders voluntary, sensory motor deficit, involuntary abnormal movements. The vertiginous patients with ataxia meet the inclusion criteria provided they do not show any other sign neurological focal, in particular, other signs of cerebellar syndrome.
  • Patient with a Glasgow score \<15 or blood glucose \< 0.70 g/l, MAP \< 65 mm Hg, acute anemia and \<7g/dl, transient dizziness having disappeared upon arrival in the emergency room, acute alcohol abuse, acute alcohol abuse, and acute drug intoxication, a history of oculomotor paralysis.
  • Patient under guardianship or curatorship.
  • Patient deprived of liberty.
  • Patient under the protection of justice.

Key Trial Info

Start Date :

October 3 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 10 2021

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT04118361

Start Date

October 3 2019

End Date

October 10 2021

Last Update

January 14 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Groupe Hospitalier Paris Saint Joseph

Paris, Île-de-France Region, France, 75014